BIO-TECHNE CORP. DL-,01/ US09073M1045 /
| 2024-11-07 8:08:18 AM | Chg. -3.00 | Volume | Bid8:58:42 PM | Ask8:58:42 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 70.00EUR | -4.11% | 0 Turnover: 0.00 |
70.50Bid Size: 150 | 71.00Ask Size: 140 | 11.31 bill.EUR | - | - |
Assets
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 176.8290 | 207.9070 | 223.2420 | 226.2000 | 251.1540 | ||||||
| Intangible Assets | 516.5450 | 615.9680 | 531.5220 | 534.6450 | 507.0810 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 1,506.6690 | 1,752.3510 | 1,689.2490 | 2,017.2100 | 2,086.4480 | ||||||
| Inventories | 103.1520 | 116.7480 | 141.1230 | 171.6380 | 179.7310 | ||||||
| Accounts Receivable | 122.5340 | 145.3850 | 194.5480 | 218.4680 | 241.3940 | ||||||
| Cash and Cash Equivalents | 146.6250 | 199.0910 | 172.5670 | 180.5710 | 151.7910 | ||||||
| Current Assets | 520.9200 | 510.6060 | 605.5560 | 621.4820 | 617.4190 | ||||||
| Total Assets | 2,027.5890 | 2,262.9570 | 2,294.8050 | 2,638.6920 | 2,703.8670 | ||||||
Liabilities
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 23.0900 | 29.3840 | 33.8650 | 25.6790 | 37.9680 | ||||||
| Long-term debt | 344.2430 | 328.8270 | 243.4100 | 350 | 319 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 101.1000 | 93.1000 | 99 | - | - | ||||||
| Liabilities | 646.3970 | 691.7230 | 593.7940 | 672.1760 | 635.0170 | ||||||
| Share Capital | 1.5400 | 1.5600 | 1.5680 | 1.5760 | 1.5820 | ||||||
| Total Equity | 1,381.1920 | 1,571.2340 | 1,701.0110 | 1,966.5160 | 2,068.8500 | ||||||
| Minority Interests | - | 8.2630 | -.7590 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 2,027.5890 | 2,262.9570 | 2,294.8050 | 2,638.6920 | 2,703.8670 | ||||||
Income Statement
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 738.6910 | 931.0320 | 1,105.5990 | 1,136.7020 | 1,159.0600 | ||||||
| Depreciation (total) | 82.7370 | 87.7470 | 101.0690 | 107.2380 | 111.7110 | ||||||
| Operating Result | 157.4190 | 237.2960 | 296.5900 | 298.9440 | 206.6860 | ||||||
| Interest Income | -18.5920 | -13.4790 | -10.5150 | -7.8050 | 3.3230 | ||||||
| Income Before Taxes | 276.4770 | 148.1750 | 301.3860 | 338.6590 | 185.6890 | ||||||
| Income Taxes | 47.1810 | 8.5900 | 38.2870 | 53.2170 | 17.5840 | ||||||
| Minority Interests Profit | - | -.8250 | -8.9520 | .1790 | 0.0000 | ||||||
| Net Income | 229.2960 | 140.4100 | 272.0510 | 285.2630 | 168.1050 | ||||||
Per Share
Cash Flow
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 205.2170 | 352.1640 | 325.2720 | 254.3930 | 298.9810 | ||||||
| Cash Flow from Investing Activities | 27.0950 | -243.5160 | -96.8510 | -265.6490 | -203.0300 | ||||||
| Cash Flow from Financing | -183.8020 | -62.5510 | -242.8530 | 22.6160 | -122.3980 | ||||||
| Decrease / Increase in Cash | 45.7390 | 52.4660 | -26.5240 | 8.0040 | -28.7800 | ||||||
| Employees | 2,300 | 2,000 | 3,000 | - | - | ||||||
